Imidazo[1,2-a]pyrimidine derivatives for treating diseases such as diabetes

Details for Australian Patent Application No. 2008314233 (hide)

Owner Merck Patent GmbH

Inventors Beier, Norbert; Klein, Markus; Tsaklakidis, Christos; Mederski, Werner

Agent Davies Collison Cave

Pub. Number AU-A-2008314233

PCT Pub. Number WO2009/049731

Priority 10 2007 048 716.0 11.10.07 DE

Filing date 13 September 2008

Wipo publication date 23 April 2009

International Classifications

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

Event Publications

3 June 2010 PCT application entered the National Phase

  PCT publication WO2009/049731 Priority application(s): WO2009/049731

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008314236-Cosmetic method for increasing the pigmentation of the skin using melanocyte precursor cells

2008314232-Machine for the production and distribution of ice particles